{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:08:57Z","timestamp":1790845737264,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.neuropharm.2007.05.002","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T20:23:17Z","timestamp":1179606197000},"page":"353-361","source":"Crossref","is-referenced-by-count":51,"title":["Venom therapy in multiple sclerosis"],"prefix":"10.1016","volume":"53","author":[{"given":"Abbas","family":"Mirshafiey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.05.002_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/02770907109108369","article-title":"Prevention of experimental allergic encephalomyelitis with cobra venom factor","volume":"8","author":"Abrahamson","year":"1971","journal-title":"J. Asthma Res."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib2","first-page":"163","article-title":"Fibrin mechanisms and functions in nervous system pathology","volume":"4","author":"Adams","year":"2004","journal-title":"Mol. Intervent"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1083\/jcb.149.5.1157","article-title":"Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury","volume":"149","author":"Akassoglou","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib4","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1073\/pnas.0303859101","article-title":"Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis","volume":"101","author":"Akassoglou","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/bip.20498","article-title":"Contribution of peptides to multiple sclerosis research","volume":"84","author":"Alcaro","year":"2006","journal-title":"Biopolymers"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0041-0101(01)00191-X","article-title":"Cytolytic peptide and protein toxins from sea anemones (Anthozoa: Actiniaria)","volume":"40","author":"Anderluh","year":"2002","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0006-3495(00)76335-1","article-title":"Mechanisms of maurotoxin action on Shaker potassium channels","volume":"79","author":"Avdonin","year":"2000","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib8","first-page":"91","article-title":"Human immune studies in multiple sclerosis","volume":"98","author":"Bar-Or","year":"2006","journal-title":"Adv. Neurol"},{"issue":"2","key":"10.1016\/j.neuropharm.2007.05.002_bib9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4049\/jimmunol.166.2.936","article-title":"Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation","volume":"166","author":"Beeton","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib10","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.1073\/pnas.241497298","article-title":"Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis","volume":"98","author":"Beeton","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib11","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1074\/jbc.M212868200","article-title":"A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes","volume":"278","author":"Beeton","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 3","key":"10.1016\/j.neuropharm.2007.05.002_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2165\/00003495-199700543-00005","article-title":"Defibrinogenating enzymes","volume":"54","author":"Bell","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/eji.1830270513","article-title":"Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects","volume":"27","author":"Bellinghausen","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0006-291X(87)90677-2","article-title":"Two potent central convulsant peptides, a bee venom toxin, the MCD peptide, and a snake venom toxin, dendrotoxin I, known to block K+ channels, have interacting receptor sites","volume":"143","author":"Bidard","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0006-8993(89)91216-X","article-title":"Analogies and differences in the mode of action and properties of binding sites (localization and mutual interactions) of two K+ channel toxins, MCD peptide and dendrotoxin I","volume":"495","author":"Bidard","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib16","first-page":"111","article-title":"Making the diagnosis of multiple sclerosis","volume":"98","author":"Birnbaum","year":"2006","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2741\/1297","article-title":"Signaling the brain in systemic inflammation: the role of complement","volume":"9","author":"Blatteis","year":"2004","journal-title":"Front. Biosci."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib18","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(83)90996-0","article-title":"Scorpion venom and multiple sclerosis","volume":"2","author":"Breland","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1196\/annals.1352.033","article-title":"Opportunities for new therapies based on the natural regulators of complement activation","volume":"1056","author":"Brook","year":"2005","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib20","first-page":"166","article-title":"Clinical study on effect of Agkistrodon antithrombogenase in auxiliary treatment of rheumatoid arthritis","volume":"22","author":"Cai","year":"2002","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0141-8130(98)00070-1","article-title":"Molecular dynamics study of kaliotoxin in water","volume":"24","author":"Canto","year":"1999","journal-title":"Int. J. Biol. Macromol"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/09638280500212062","article-title":"Use of complementary and alternative medicine practitioners by people with physical disabilities: estimates from a National US Survey. Disabil","volume":"28","author":"Carlson","year":"2006","journal-title":"Rehabil."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00018-003-3325-z","article-title":"Snake venom thrombin-like enzymes: from reptilase to now","volume":"61","author":"Castro","year":"2004","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib24","first-page":"470","article-title":"A phase I study of the safety of honeybee venom extract as a possible treatment for patients with progressive forms of multiple sclerosis","volume":"26","author":"Castro","year":"2005","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib25","first-page":"57","article-title":"A therapeutic bee sting?","volume":"61","author":"Cerrato","year":"1998","journal-title":"RN"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0041-0101(00)00152-5","article-title":"Purification and characterization of calobin II, a second type of thrombin-like enzyme from Agkistrodon caliginosus (Korean viper)","volume":"39","author":"Cho","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib27","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0021-9258(18)45993-5","article-title":"Kaliotoxin, a novel peptidyl inhibitor of neuronal BK-type Ca(2+)-activated K+ channels characterized from Androctonus mauretanicus mauretanicus venom","volume":"267","author":"Crest","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.toxicon.2003.11.020","article-title":"Cross-reactivity and inhibition of\u00a0haemolysis by polyclonal antibodies raised against St\u00a0II, a cytolysin from the sea anemone Stichodactyla helianthus","volume":"43","author":"Cristina Pico","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib29","first-page":"147","article-title":"Oriental hornet venom enhances wound healing and repair in rat skin, possibly through its collagenolytic activity","volume":"40","author":"Dayan","year":"1983","journal-title":"Acta Trop"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib30","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood.V96.8.2793","article-title":"Analysis of fibrin formation and proteolysis during intravenous administration of ancrod","volume":"96","author":"Dempfle","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0049-3848(01)00391-7","article-title":"Plasminogen activation without changes in tPA and PAI-1 in response to subcutaneous administration of ancrod","volume":"104","author":"Dempfle","year":"2001","journal-title":"Thromb. Res."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1749-6632.2001.tb03507.x","article-title":"Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity","volume":"936","author":"Dempfle","year":"2001","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib33","first-page":"257","article-title":"Use of interferon-beta in the treatment of multiple sclerosis","volume":"98","author":"Derwenskus","year":"2006","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib34","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0035-3787(04)71001-2","article-title":"Ion channels and demyelination: basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers","volume":"160","author":"Devaux","year":"2004","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib35","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/bi9721086","article-title":"Consequence of the removal of evolutionary conserved disulfide bridges on the structure and function of charybdotoxin and evidence that particular cysteine spacings govern specific disulfide bond formation","volume":"37","author":"Drakopoulou","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(96)13164-5","article-title":"Blockade of voltage-gated outward K+ currents of ramified murine microglia by scorpion peptide toxins","volume":"219","author":"Eder","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib37","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0006-2952(82)90354-9","article-title":"Effect of honeybee (Apis mellifera) venom on course of adjuvant-induced arthritis and depression of drug metabolism in the rat","volume":"31","author":"Eiseman","year":"1982","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib38","first-page":"797","article-title":"Emerging therapies in multiple sclerosis. Expert Opin. Emerg","volume":"10","author":"Farrell","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib39","doi-asserted-by":"crossref","first-page":"14256","DOI":"10.1021\/bi00251a038","article-title":"Kaliotoxin (1\u201337) shows structural differences with related potassium channel blockers","volume":"33","author":"Fernandez","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib40","article-title":"Bee venom and chronic inflammatory disease","volume":"99","author":"Fisher","year":"1986","journal-title":"N.Z. Med. J."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1432-1033.1993.tb17613.x","article-title":"Sequence-specific 1H-NMR assignment and secondary structure of black mamba dendrotoxin I, a highly selective blocker of voltage-gated potassium channels","volume":"211","author":"Foray","year":"1993","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib42","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1021\/bi00399a004","article-title":"Role of tyrosine and tryptophan residues in the structure-activity relationships of a cardiotoxin from Naja nigricollis venom","volume":"26","author":"Gatineau","year":"1987","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib43","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s10541-005-0207-z","article-title":"Inhibition of Naja naja venom hyaluronidase by plant-derived bioactive components and polysaccharides","volume":"70","author":"Girish","year":"2005","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3949\/ccjm.73.2.177","article-title":"Multiple sclerosis: treating symptoms, and other general medical issues","volume":"73","author":"Goldman","year":"2006","journal-title":"Cleve Clin. J. Med."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib45","first-page":"96","article-title":"Treatment of multiple sclerosis with human beta interferon","volume":"12","author":"Goodin","year":"2005","journal-title":"Int. MS J"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib46","first-page":"22","article-title":"Enzymes of snake venoms","volume":"75","author":"Gornitskaia","year":"2003","journal-title":"Ukr. Biokhim. Zh"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib47","first-page":"1227","article-title":"Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines","volume":"45","author":"Grissmer","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/08923970500418943","article-title":"Bee venom, immunostimulant or immunosuppressor?, insight into the effect on matrix metalloproteinases and interferons","volume":"27","author":"Hamedani","year":"2005","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0041-0101(94)00181-7","article-title":"Structure-activity studies on scorpion toxins that block potassium channels","volume":"33","author":"Harvey","year":"1995","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.toxicon.2004.06.003","article-title":"Cloning and purification of alpha-neurotoxins from king cobra (Ophiophagus hannah)","volume":"44","author":"He","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib51","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.0953-816x.2001.01699.x","article-title":"Beta-bungarotoxin is a potent inducer of apoptosis in cultured rat neurons by receptor-mediated internalization","volume":"14","author":"Herkert","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib52","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/08923979909007122","article-title":"Sequence determinants of modified cobra venom neurotoxin which induce immune resistance to experimental allergic encephalomyelitis: molecular mechanisms for immunologic action","volume":"21","author":"Hinman","year":"1999","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0161-5890(83)90135-9","article-title":"Experimental allergic encephalomyelitis: prevention with a nontoxic derivative of a cobra neurotoxin","volume":"20","author":"Hudson","year":"1983","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib54","first-page":"5","article-title":"A review of the evidence for efficacy of complementary and alternative medicines in MS","volume":"13","author":"Huntley","year":"2006","journal-title":"Int. MS J"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-5728(96)00150-6","article-title":"Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis rats","volume":"71","author":"Inoue","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib56","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0049-3848(99)00135-8","article-title":"Changes in mRNA levels of fibrinogen subunit polypeptides in rats defibrinogenated with batroxobin","volume":"96","author":"Iwai","year":"1999","journal-title":"Thromb. Res."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1254\/jphs.91.95","article-title":"Bee venom induces apoptosis and inhibit expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCL-H1299","volume":"91","author":"Jang","year":"2003","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib58","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1517\/14728222.6.6.623","article-title":"The Ca2+-activated K+ channel of intermediate conductance: a possible target for immune suppression","volume":"6","author":"Jensen","year":"2002","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.pharmthera.2005.10.006","article-title":"Potassium channel blockers in multiple sclerosis: neuronal K(v) channels and effects of symptomatic treatment","volume":"111","author":"Judge","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/taap.2002.9416","article-title":"Identification of PLA(2) and alpha-neurotoxin proteins in the venom of Pseudonaja affinis (dugite)","volume":"181","author":"Judge","year":"2002","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib61","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.4049\/jimmunol.154.8.4187","article-title":"Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures","volume":"154","author":"Jutel","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1142\/S0192415X02000089","article-title":"The effect of whole bee venom on arthritis","volume":"30","author":"Kang","year":"2002","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib63","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0014-5793(97)00285-8","article-title":"a four disulfide bridge toxin from Scorpio maurus venom: purification, structure and action on potassium channels","volume":"406","author":"Kharrat","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1292\/jvms.65.349","article-title":"Acupoint stimulation using bee venom attenuates formalin-induced pain behavior and spinal cord fos expression in rats","volume":"65","author":"Kim","year":"2003","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib65","doi-asserted-by":"crossref","first-page":"30836","DOI":"10.1074\/jbc.M403196200","article-title":"Structure and function of recombinant cobra venom factor","volume":"279","author":"Kock","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib66","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0304-3959(00)00412-7","article-title":"Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses","volume":"90","author":"Kwon","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0024-3205(02)01617-X","article-title":"The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats","volume":"71","author":"Kwon","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib68","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2826.2003.00951.x","article-title":"The anti-inflammatory effect of bee venom stimulation in a mouse air pouch model is mediated by adrenal medullary activity","volume":"15","author":"Kwon","year":"2003","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib69","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nsb0494-246","article-title":"Proteinase inhibitor homologues as potassium channel blockers","volume":"1","author":"Lancelin","year":"1994","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib70","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF01824737","article-title":"Ueber das Gift un serer Monig biene","volume":"38","author":"Langer","year":"1897","journal-title":"Arch. Exp. Path. Pharmak"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib71","doi-asserted-by":"crossref","first-page":"15528","DOI":"10.1021\/bi011300b","article-title":"Designed peptide analogues of the potassium channel blocker ShK toxin","volume":"40","author":"Lanigan","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0304-3959(96)03075-8","article-title":"The bee venom test. A new tonic-pain test","volume":"66","author":"Lariviere","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib73","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1292\/jvms.63.251","article-title":"Bee venom pretreatment has both an antinociceptive and anti-inflammatory effect on carrageenan-induced inflammation","volume":"63","author":"Lee","year":"2001","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib74","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3181\/00379727-138-35880","article-title":"Allergic encephalomyelitis: effect of complement depletion with cobra venom","volume":"138","author":"Levine","year":"1971","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib75","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/brain\/112.4.895","article-title":"The role of complement in the pathogenesis of experimental allergic encephalomyelitis","volume":"112","author":"Linington","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib76","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1211\/002235702320266235","article-title":"Effect of honeybee venom on proliferation of K1735M2 mouse melanoma cells in vitro and growth of murine B16 melanomas in vivo","volume":"54","author":"Liu","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib77","first-page":"30","article-title":"Expression of neurotoxin II from Naja oxiana cobra venom in Escherichia coli in a hybrid form with thioredoxin","volume":"30","author":"Liukmanova","year":"2004","journal-title":"Bioorg. Khim"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0896-6273(90)90450-T","article-title":"Subconductance behavior in a maxi Ca2(+)-activated K+ channel induced by dendrotoxin-I","volume":"4","author":"Lucchesi","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib79","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1046\/j.1365-2222.2001.01171.x","article-title":"Venom immunotherapy induces monocyte activation","volume":"31","author":"Magnan","year":"2001","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib80","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.str.2003.09.019","article-title":"Crystal and electron microscopy structures of sticholysin II actinoporin reveal insights into the mechanism of membrane pore formation","volume":"11","author":"Mancheno","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib81","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.toxicon.2005.02.016","article-title":"Practical applications of snake venom toxins in haemostasis","volume":"45","author":"Marsh","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib82","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/bj3040051","article-title":"Novel K(+)-channel-blocking toxins from the venom of the scorpion Centruroides limpidus limpidus Karsch","volume":"304","author":"Martin","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib83","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0041-0101(01)00127-1","article-title":"Properties of St I and St II, two isotoxins isolated from Stichodactyla helianthus: a comparison","volume":"39","author":"Martinez","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib84","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0041-0101(02)00101-0","article-title":"Identity between cytolysins purified from two morphos of the Caribbean sea anemone Stichodactyla helianthus","volume":"40","author":"Martinez","year":"2002","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib85","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1055\/s-0038-1645064","article-title":"Studies on blood coagulation and fibrinolysis in patients bitten by Bothrops jararaca (jararaca)","volume":"63","author":"Maruyama","year":"1990","journal-title":"Thromb. Haemost"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib86","doi-asserted-by":"crossref","first-page":"13698","DOI":"10.1021\/bi035209e","article-title":"Substitution of a single residue in Stichodactyla helianthus peptide, ShK-Dap22, reveals a novel pharmacological profile","volume":"42","author":"Middleton","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib87","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.410040507","article-title":"Experimental allergic encephalomyelitis in cobra venom factor-treated and C4-deficient guinea pigs","volume":"4","author":"Morariu","year":"1978","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib88","article-title":"Complementary and alternative medicine for MS","volume":"13","author":"Murray","year":"2006","journal-title":"Int. MS J"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib89","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF02976695","article-title":"Inhibition of COX-2 activity and proinflammatory cytokines (TNF-alpha and IL-1beta) production by water-soluble sub-fractionated parts from bee (Apis mellifera) venom","volume":"26","author":"Nam","year":"2003","journal-title":"Arch. Pharm. Res."},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2007.05.002_bib90","first-page":"263","article-title":"Potassium channels and epilepsy: evidence that the epileptogenic toxin, dendrotoxin, binds to potassium channel proteins","volume":"4","author":"Newitt","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib91","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1399-3011.1998.tb01226.x","article-title":"Chemical synthesis of dendrotoxin-I: revision of the reported structure","volume":"51","author":"Nishio","year":"1998","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib92","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.2174\/0929867043363947","article-title":"Potassium channel blockade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other autoimmune diseases","volume":"11","author":"Norton","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib93","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0041-0101(94)90309-3","article-title":"Purification and characterization of a coagulant enzyme, okinaxobin II, from Trimeresurus okinavensis (himehabu snake) venom which release fibrinopeptides A and B","volume":"32","author":"Nose","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib94","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.toxicon.2004.09.014","article-title":"Weak neurotoxin from Naja kaouthia cobra venom affects haemodynamic regulation by acting on acetylcholine receptors","volume":"45","author":"Ogay","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib95","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0041-0101(03)00045-X","article-title":"Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom","volume":"41","author":"Orsolic","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib96","first-page":"2428","article-title":"Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation in rats","volume":"35","author":"Paterson","year":"1976","journal-title":"Fed. Proc."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib97","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0041-0101(03)00227-7","article-title":"Comparison of pore-forming ability in membranes of a native and a recombinant variant of Sticholysin II from Stichodactyla helianthus","volume":"42","author":"Pazos","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib98","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/hum.2005.16.292","article-title":"Protective immunity against alpha-cobratoxin following a single administration of a genetic vaccine encoding a non-toxic cobratoxin variant","volume":"16","author":"Pergolizzi","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib99","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1590\/S0100-879X2000001100005","article-title":"Two related thrombin-like enzymes present in Bothrops atrox venom","volume":"33","author":"Petretski","year":"2000","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2249.1991.tb05622.x","article-title":"Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation","volume":"83","author":"Piddlesden","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib101","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1021\/bi00406a005","article-title":"The receptor site for the bee venom mast cell degranulating peptide. Affinity labeling and evidence for a common molecular target for mast cell degranulating peptide and dendrotoxin I, a snake toxin active on K+ channels","volume":"27","author":"Rehm","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib102","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1021\/bi971044w","article-title":"synthesis of three novel toxins from the Chinese scorpion Buthus martensi, which act on K+ channels","volume":"36","author":"Romi-Lebrun","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib103","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev.en.27.010182.002011","article-title":"Biochemistry of insect venom","volume":"27","author":"Schmidt","year":"1982","journal-title":"Ann. Rev. Ent."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib104","doi-asserted-by":"crossref","first-page":"8346","DOI":"10.1021\/bi00447a012","article-title":"Cross-linking of beta-bungarotoxin to chick brain membranes. Identification of subunits of a putative voltage-gated K+ channel","volume":"28","author":"Schmidt","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-2004-830248","article-title":"Alternative and complementary therapies in multiple sclerosis","volume":"73","author":"Schwarz","year":"2005","journal-title":"Fortschr. Neurol. Psychiatr."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2007.05.002_bib106","first-page":"s48","article-title":"Ancrod","volume":"18","author":"Sherman","year":"2002","journal-title":"Curr. Med. Res. Opin"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib107","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ctim.2005.07.007","article-title":"The perceived benefit and satisfaction from conventional and complementary and alternative medicine (CAM) in people with multiple sclerosis","volume":"13","author":"Shinto","year":"2005","journal-title":"Complement Ther. Med."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib108","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1191\/1352458506ms1230oa","article-title":"Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis","volume":"12","author":"Shinto","year":"2006","journal-title":"Multiple Sclerosis"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2007.05.002_bib109","doi-asserted-by":"crossref","first-page":"I32","DOI":"10.1007\/s00415-006-1108-9","article-title":"Current issues in immunomodulatory treatment of multiple sclerosis\u2014a practical approach","volume":"253","author":"Stangel","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib110","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1084\/jem.186.7.1015","article-title":"Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon gamma: a possible initiating role of B cells","volume":"186","author":"Tsuji","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib111","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1602\/neurorx.2.4.638","article-title":"Developing therapeutics for the treatment of multiple sclerosis","volume":"2","author":"Virley","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-004-4205-6","article-title":"Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro","volume":"73","author":"Wang","year":"2005","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib113","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1107\/S0907444902003645","article-title":"Crystallization of bothrombin, a fibrinogen-converting serine protease isolated from the venom of Bothrops jararaca","volume":"58","author":"Watanabe","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib114","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1212\/01.wnl.0000184442.02551.4b","article-title":"A randomized crossover study of bee sting therapy for multiple sclerosis","volume":"65","author":"Wesselius","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2007.05.002_bib115","first-page":"297","article-title":"Effects of batroxobin on spatial learning and memory disorder of rats with temporal ischemia and the expression of HSP32 and HSP70","volume":"20","author":"Wu","year":"2000","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib116","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI16921","article-title":"The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS","volume":"111","author":"Wulff","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib117","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11910-006-0014-y","article-title":"Complementary and alternative medicine: is there a role in multiple sclerosis?","volume":"6","author":"Yadav","year":"2006","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib118","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1124\/mol.105.011064","article-title":"Stichodactyla helianthus peptide, a pharmacological tool for studying Kv3.2 channels","volume":"67","author":"Yan","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib119","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.febslet.2004.06.060","article-title":"Functional characterization of recombinant batroxobin, a snake venom thrombin-like enzyme, expressed from Pichia pastoris","volume":"571","author":"You","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib120","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1529\/biophysj.103.039461","article-title":"Computational simulations of interactions of scorpion toxins with the voltage-gated potassium ion channel","volume":"86","author":"Yu","year":"2004","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2007.05.002_bib121","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0161-813X(02)00019-0","article-title":"The effect of snake venoms and their components on adrenomedullary cells: catecholamine efflux and cell damage","volume":"23","author":"Zhang","year":"2002","journal-title":"Neurotoxicology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807001293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807001293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T11:52:09Z","timestamp":1707911529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807001293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0028390807001293"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.05.002","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}